WE01-WE03
Exclusion criteria included: type 1 diabetes, either acute or chronic pancreatitis, proliferative diabetic retinopathy or macular diabetes, non-proliferative diabetic retinopathy requiring urgent treatment, either acute or chronic hepatopathy with clinic or laboratory evidence of liver injury (e.g., 3-fold elevation in plasmatic transaminases), severe hypoglycemia or unawareness hypoglycemia, gastroparesis, previous bariatric surgery, concomitant use of certain medications delaying gastric emptying, established coronary disease or severe chronic heart failure (NYHA class III or IV), glomerular filtration rate 50%
Studies found that patients saw moderate to low weight loss results with SGLT2 inhibitors
(National Academy Press) Schleicher RL, Carroll MD, Ford ES, Lacher DA
Among people using the drugs without diabetes, discontinuation rose to around 65%